Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KRT17 as a prognostic biomarker for stage II colorectal cancer

20 Nov 2019

Abstract excerpt

Adjuvant chemotherapy is considered for patients with stage II colorectal cancer (CRC) characterized by poor prognostic clinicopathological features; however, current stratification algorithms remain inadequate for identifying high-risk patients. To develop prognostic assays, we conducted a step-wise screening and validation strategy using nine cohorts of stage II patients based on multiple platforms, including...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Screening and Detection
Share to Colorectal Cancer Treatments and Studies
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31754689
DOI: 10.1093/carcin/bgz192

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KRT17 as a prognostic biomarker for stage II colorectal cancerPMID 31754689Read ↗

KRT17 Serves as an Oncogene and a Predictor of Poor Survival in Hepatocellular Carcinoma PatientsSemantic proximity Read ↗

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancerSemantic proximity Read ↗

Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal CancerSemantic proximity Read ↗

Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.Semantic proximity Read ↗

Molecular profiling of risk factors for relapse in Japanese patients with stage II colorectal cancer: a retrospective cohort study.Semantic proximity Read ↗

Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer.Semantic proximity Read ↗

Keratin 17 Drives Endometrial Cancer Aggressiveness via Epithelial-Mesenchymal Transition: A Single-Cell Transcriptomic and Integrative Bioinformatics StudySemantic proximity Read ↗

Cross-Cohort Evaluation of NanoString nCounter Data for Recurrence Prediction in Colorectal CancerSemantic proximity Read ↗

Keratin 17 is a prognostic biomarker in endometrial carcinoma and correlates with immune invasionSemantic proximity Read ↗

Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancerSemantic proximity Read ↗

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.Semantic proximity Read ↗

Transcriptomic profiling reveals an enhancer RNA signature for recurrence prediction in colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.